Table 4 NOD2 and LCT mutation distribution in MAP infected and non-infected individuals among Crohn’s disease (CD), ulcerative colitis (UC) and in control (HC) cohorts [ n (%)]
Number of mutations | CD (n = 173) | UC (n = 105) | HC (n = 188) | |||
|---|---|---|---|---|---|---|
MAP + | MAP - | MAP + | MAP - | MAP + | MAP - | |
NOD2 | ||||||
0 | 29 (16.76) | 103 (59.54) | 19 (18.10) | 77 (40.96) | 77 (40.96) | 87 (46.28) |
1 | 7 (4.05) | 26 (15.03) | 1 (0.95) | 7 (6.67) | 8 (4.26) | 16 (8.51) |
2 | 1 (0.58) | 7 (4.05) | 0 (0.00) | 1 (0.95) | 0 (0.0) | 0 (0.00) |
LCT | ||||||
0 | 27 (15.61) | 109 (63.01) | 14 (13.33) | 64 (60.95) | 73 (38.83) | 80 (42.55) |
1 | 10 (5.78) | 27 (15.61) | 6 (5.71) | 21 (20.00) | 12 (6.38) | 23 (12.23) |